• हिन्दी
  • ગુજરાતી
  • বাংলা
  • తెలుగు
  • मराठी
  • ಕನ್ನಡ
  • money9
  • Insurance
  • Saving
  • Mutual Funds
  • Mirae Asset MF
  • Breaking Briefs
downloadDownload The App
Close
  • Home
  • Videos
  • Podcast
  • Banking
  • Bulletin
  • Gold
  • Healthcare
  • Real Estate
  • Tax
  • Travel
  • Survey 2023
  • Survey Report
  • Breaking Briefs
  • Insurance
  • Savings
  • Loan
  • Crypto
  • Investment
  • Mutual Funds
  • Real Estate
  • Tax
  • Exclusive
  • Home / Covid Update

More than 70% Covid-19 patients are above 40 years old

Prevalence of shortness of breath is slightly higher in the second wave of COVID-19 but sore throat and dry cough and other symptoms were higher in the first wave

  • Press Trust of India
  • Last Updated : April 19, 2021, 18:20 IST
  • Follow
  • Follow

New Delhi: More than 70% of COVID-19 patients over 40 years of age in both the waves and older population continues to be more vulnerable to the infection, the Centre said on Monday.

Addressing media, ICMR Director General Balram Bhargava said there is no difference in deaths between first and second wave among hospitalised patients, while the oxygen requirement is higher in second wave and ventilator requirement is not higher in the second wave.

Prevalence of shortness of breath is slightly higher in the second wave of COVID-19 but sore throat and dry cough and other symptoms were higher in the first wave, the Centre said on Monday.

“No difference in deaths between first and second wave among hospitalised patients. About 54.5 per cent patients require oxygen in second wave against 41.5 per cent in the first wave,” he said.

“More than 70% patients in both waves are more than 40 years old, only marginally higher proportion of younger patients. Higher proportion of asymptomatic patients in the second wave,” he said, based on the study of 1,885 patients in second wave and 7,600 patients in the first wave.

NITI Aayog Member (Health) V K Paul said in the first wave 31% patients were aged less than 30 years, this time it is up to 32%. “Essentially there is no difference,” Paul said.

Bhargava appealed that wastage of oxygen must not happen and it should be rationalised. Paul added that remdesivir must be used on hospitalised patients in moderate stages of illness on oxygen and it is not to be used in home settings.

Published: April 19, 2021, 18:20 IST

Download Money9 App for the latest updates on Personal Finance.

  • Covid
  • ICMR
  • Niti Aayog

Related

  • Covid first wave led to increase in antibiotic misuse in India: Study
  • Centre rushes teams to six states reporting a high number of Covid cases
  • Covid-19: India records 46,617 new cases; national recovery rate crosses 97%
  • India’s medical infrastructure well prepared to deal with possible third Covid wave, says FM
  • Karnataka makes RT-PCR negative report, vaccine certificate must for Kerala travellers
  • National Doctors’ Day: Over 1500 doctors sacrificed their lives in fight against Covid-19

Latest

  • 1. Know the correct way to get KYC done!
  • 2. Why health insurance claim gets rejected?
  • 3. Power to Respond!
  • 4. What is Asset Under Management?
  • 5. No Worries on Medical Expenses!
  • Trending Stories

  • DGCA प्रमुख ने सुचारू उड़ान संचालन सुनिश्चित करने के लिए पायलटों से मांगा सहयोग
  • रेपो दर में कटौती से घर के लिए कर्ज होगा सस्ता, मांग बढ़ेगी: रियल एस्टेट
  • मीशो के 5,421 करोड़ रुपये के आईपीओ को दूसरे दिन मिला 7.97 गुना अभिदान
  • इंडिगो को अगले साल 10 फरवरी तक उड़ान संचालन पूरी तरह बहाल होने की उम्मीद
  • Indigo की 200 से ज्यादा फ्लाइट रद्द, हजारों पैसेंजर फंसे
  • TV9 Sites

  • TV9 Hindi
  • TV9Telugu.com
  • TV9 Marathi
  • TV9 Gujarati
  • TV9 Kannada
  • TV9 Bangla
  • TV9 English
  • News9 Live
  • Trends9
  • Tv9tamilnews
  • Assamtv9
  • Malayalamtv9
  • Money9 Sites

  • Money9 Hindi
  • Money9 English
  • Money9 Marathi
  • Money9 Telugu
  • Money9 Gujarati
  • Money9 Kannada
  • Money9 Bangla
  • Money9live
  • Topics

  • Insurance
  • Savings
  • Loan
  • Stocks
  • Mutual Funds
  • Real Estate
  • Tax
  • Crypto
  • Exclusive
  • Follow us

  • FaceBook
  • Twitter
  • Youtube
  • Instagram
  • Linkedin
  • Download App

  • play_store
  • App_store
  • Contact Us
  • About Us
  • Advertise With Us
  • Privacy & Cookies Notice
  • Complaint Redressal
  • Copyright © 2025 Money9. All rights reserved.
  • share
  • Facebook
  • Twitter
  • Whatsapp
  • LinkedIn
  • Telegram
close